Q-A 1
Q (t) My
question is adressed to Dr Avicenne, and concerns products
based on shark cartilage. I would like to know if clinical
studies have been carried out with such products, related to
retinitis and Crohn disease. Do you think that this product
could be useful in these diseases treatment (the same person
is affected by the two diseases) ?
|
A (t)
As we mentionned
in the article published in N°23 of our paper "Sida
Tout Va Bien", and in the article appearing on our Internet
website <http://www.positifs.org/ (chapter
C.14.), shark
cartilage may have an interest in some diseases.
Some of its components,
alkyls glycerols, would have an action on certain tumors.
Another of its components, an angiogenesis inhibitor (small
vessels formation appearing excessively and anarchically in
some diseases), wich composition is unknown because of the
existence of a patent, would have an action on diseases
involving an angiogenesis anomaly : Kaposi's Sarcoma (in
AIDS), some solid tumors (prostate, uterus, colon),
rheumatoid arthritis, psoriasis, diabetic
retinopathy.
Concerning pigmental
retinitis and Crohn disease, we have no information of the
possible action of shark cartilage. You may contact Mr
Thierry Lerond (Nutrilys, 18 av. M. Anthonioz, 01220 Divonne
les Bains, France ; Tel : +33 (0)4 50 20 40 22, Fax : +33
(0)4 50 20 77 76).
Concerning Crohn disease,
it is an immunologic disease, wich anomaly is close to the
rheumatoid arthritis. We can ask if shark cartilage would't
have an interest ; but we hadn't time to see if Crohn
disease is caracterised by an angiogenesis anomaly, which
would be an argument to consider this treatment.
(9703)
|
Q-A 2
Q (t) I
saw at this address <http://www.positifs.org/c/c-14.htm> that Roquinimex would have
some effects against Kaposi's Sarcoma. I would like to know
more.
The document seems
rather old, therefore, I would like to know where is it
possible to get it now, and at wich cost. Then I would like
to know if the described effects have been proved, and under
wich conditions. You can imagine that your interlocutor has
AIDS with a Kaposi Sarcoma.
|
A (t)
Indeed we added,
less than a year ago, an information on the roquinimex in
our article on shark cartilage, on the Internet Positifs
website.
Roquinimex (Linomide) is an angiogenesis inhibitor that has
been used in a double blind protocole against placebo in an
hospital unit in Paris (France).
The first results seemed encouraging on the Kaposi's Sarcoma
with, appearently, an action on some immunity biological
parameters.
To the last news, this protocole would have been stopped,
for unclear reasons. One patient contacted us, saying that
his Kaposi's Sarcoma had improved, as well as his biological
parameters. But this patient had stop the protocole because
of a pericarditis. Considering the obtained results, this
patient is sure to have used this medecine and not the
placebo (wich seems probable). On the other hand, the
protocole responsibles affirm after checking that he
actually received the placebo, and that her pericarditis
would be due to the HIV (which is not impossible). But we
may ask questions, as pericarditis is the only worrying side
effect of the roquinimex !
You could try to have more informations by contacting Dr
Zylberbert (+33 (0)1 42 34 19 51), on of this protocole
experimentators. (9705)
|
Q-A 3
Q (t)
Congratulations for your very interesting site. Could you
indicate me where to obtain shark cartilage and Roquinimex
?
Thank you for
help.
Sincerely.
|
A (t)
Concerning shark
cartilage, you must know that several presentations exist on
sale, wich don't contain the presumed efficient products in
sufficient quantity, and are saled at extremely expensive
prices.
You could contact concerning this subjects Mr Thierry Lerond
(Nutrilys, 18 av. M. Anthonioz, 01220 Divonne les Bains,
France ; Tel : +33 (0)4 50 20 40 22, Fax : +33 (0)4 50 20 77
76).
Concerning Roquinimex
(Linomide), it is an angiogenesis inhibitor that has been
used in a double blind protocole against placebo in an
hospital unit in Paris (France).
The first results seemed encouraging on the Kaposi's Sarcoma
with, appearently, an action on some immunity biological
parameters.
To the last news, this protocole would have been stopped,
for unclear reasons. One patient contacted us, saying that
his Kaposi's Sarcoma had improved, as well as his biological
parameters. But this patient had stop the protocole because
of a pericarditis. Considering the obtained results, this
patient is sure to have used this medecine and not the
placebo (wich seems probable). On the other hand, the
protocole responsibles affirm after checking that he
actually received the placebo, and that her pericarditis
would be due to the HIV (which is not impossible). But we
may ask questions, as pericarditis is the only worrying side
effect of the roquinimex !
You could try to have more informations by contacting Dr
Zylberbert (+33 (0)1 42 34 19 51), on of this protocole
experimentators. (9705)
|
